Science & Technology
(U500)
IRS Verified
DX Registered
990 on File
SALK INSTITUTE FOR BIOLOGICAL STUDIES
Financial strength (30%)
70/100
Reliability (20%)
55/100
Effectiveness (25%)
88/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2024
$161.2M
Total Revenue
$177.2M
Total Expenses
$649.4M
Net Assets
1144
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
83.1%
Fundraising Efficiency
4305.0%
Operating Reserve
43.97x
Liability-to-Asset
21.1%
Revenue Diversification
86.5%
Executive Compensation
$3.1M
Compared with Peers
FY 2024
Compared with 32 similar organizations
(United States, Science & Technology, $100M and over in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
83.1% | 88.7% |
P10P90
|
Bottom quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
13.2% | 11.5% |
P10P90
|
Below median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
3.7% | 0.0% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
44.0 mo | 6.5 mo |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
21.1% | 42.4% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
86.5% | 95.6% |
P10P90
|
Top quarter |
|
Revenue growth
Year over year revenue growth
|
-7.2% | 11.6% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
5.9% | 10.3% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-10.0% | 1.0% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $161.2M | $177.2M | $649.4M | 83.1% | 1144 |
| 2023 | $173.7M | $167.4M | $632.3M | 82.7% | 1144 |
| 2022 | $162.3M | $161.4M | $615.4M | 83.1% | 1190 |
| 2021 | $388.1M | $148.4M | N/A | — | 1131 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.